Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...
An elbow-injury epidemic has become an existential threat to the sport, prompting the M.L.B. to brainstorm new solutions, ...
Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive ...
San Diego Padres starter Yu Darvish was recently treated by Keith Meister, MD, for elbow inflammation before the start of the ...
(Reuters) - Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would ...
Investing.com -- Illumina shares rose over 2% premarket on Tuesday, following a Wall Street Journal report that activist ...
(Reuters) - Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would take ...